A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
Key facts
- Who runs it
- Negovsky Reanimatology Research Institute
- Where
- Russia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- Phase
- Phase 3
- People taking part
- 107 people enrolled
- Started
- 20 Nov 2021
- Ended
- 19 May 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Lithium Carbonate
- Placebo
- Record updated
- 25 September 2025
- Why it stopped
- Decision of the local ethics committee
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- age > 18 years
- elective carotid artery surgery
- general anesthesia
- written informed consent
Who cannot take part
- urgent surgery
- Previously enrolled in this trial
- recent ( < 1 month) overt stroke
- The presence of any mental disorder according to the International Classification of Diseases 11th Revision which is confirmed by a psychiatrist
- The presence of any neuromuscular disease according to the International Classification of Diseases 11th Revision
- Hypersensitivity or known allergy to lithium carbonate
- History of seizure disorder
- History of leukemia
- Heart failure equal 3 or 4 class according to the New York Heart Association Functional Classification
- Left ventricular ejection fraction < 30%
- Mini-mental State Examination < 20 points
- Estimated glomerular filtration rate < 30 ml/min/1.73 m2
- Pregnant or breast-feeding women
- Inability to undergo a preoperative assessment for any reason
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
There are 10.3 million cases of stroke registered in the world every year; 63% of them lead to death. According to World Health Organization, stroke is one of the most important risk factors of death and early disability.
Read full original descriptionShow less
Carotid artery surgery is a gold standard of hemodynamically significant carotid artery disease treatment. According to some trials, carotid artery surgery decreases the 2-years mortality.
The most important part of carotid artery surgery is a temporary absence of blood flow in the carotid artery. The duration of this period is a crucial characteristic of this type of surgery. The absence of blood flow leads to brain ischemia which is the risk factor of postoperative neurocognitive disorders such as emergence delirium, postoperative delirium and postoperative cognitive dysfunction.
Some surgical and non-surgical methods for brain protection were evaluated. According to recent data, there is no evidence of effective pharmacological protective methods that can decrease brain damage during carotid artery surgery.
Nevertheless, some trials demonstrated that using lithium-based medications for patients with a stroke can reduce the volume of the stroke. Therefore, the investigators want to check the hypothesis that using lithium-based medication in the preoperative period can reduce brain damage during carotid artery surgery.
The objectives of this trial:
1. To determine if Lithium carbonate is superior to placebo for the occurrence of emergence delirium, agitation, postoperative delirium and postoperative cognitive dysfunction. 2. To determine if Lithium carbonate is non-inferior to placebo for the occurrence of a new arrhythmia, leukocytosis, acute kidney injury, seizure disorders, diarrhea, nausea, and vomit.
The 2 groups in the trial
- LithiumTreatment being tested
In preoperative period patients will take 300mg of lithium carbonate on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take 300mg of lithium carbonate 2 hours before surgery. After the surgery, patients will take 300mg of lithium carbonate in the afternoon and 300mg of lithium carbonate in the evening.
Treatment: Lithium Carbonate
- PlaceboPlacebo, for comparison
In preoperative period patients will take placebo on 1-1-1 regimen during 2 days prior to surgery. On the day of surgery, they will take placebo 2 hours before surgery. After the surgery, patients will take placebo in the afternoon and in the evening.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction: A Double-Blind, Placebo Control Randomized Trial (BINOS)
- Record updated
- 25 September 2025